$UL

Unilever Share Price Target Lifted at BofA, TD Cowen Following Strong Q2 Results

Unilever’s Q2 results beat expectations, prompting price target increases from TD Cowen and BofA. TD Cowen raised its target to $76 from $67, citing a 5.8% volume-led sales beat and EPS of EUR 1.61 vs EUR 1.59 consensus, and said management gained confidence to lift its H2 outlook. BofA lifted its target to $76 from $72 and raised EPS estimates for 2026-2028.

Original reporting
Published Jul 29, 2026, 3:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 4:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Unilever Share Price Target Lifted at BofA, TD Cowen Following Strong Q2 Results — source image
Decision brief

The 30-second read

$ULBullishMed
01

Why it matters

Two analysts raised price targets to $76 and BofA increased EPS estimates for 2026-2028 by 1% each, citing volume/mix outperformance and confidence in a higher H2 sales outlook.

02

Market read

The key tradable input is the convergence of bullish sell-side revisions to $76, anchored to specific Q2 beat metrics and an implied H2 outlook raise.

03

What to watch

The article does not quantify the magnitude or timing of the raised H2 sales outlook, nor does it address valuation or margin sustainability, which could drive follow-through versus mean reversion.

Relevance 7/10Novelty 6/10Timing: same-day analyst price target increases after Q2 results

Background

Unilever reported a better-than-expected Q2 with a volume-led sales beat and slightly higher EPS, prompting sell-side optimism.

Company-level read

Ticker impact

$ULBullishMedium confidence
Context

Unilever shares saw two same-day price target lifts after a better-than-expected Q2 volume-led sales beat and EPS outperformance.

Expected impact

Bias modestly positive for the next few sessions as the market digests the raised outlook and higher EPS estimates.

Evidence & confidence

The article provides concrete analyst target changes ($67 to $76, $72 to $76) tied to specific Q2 metrics (volume-led sales beat 5.8% vs 4.3% consensus; EPS EUR 1.61 vs EUR 1.59) and an implied H2 outlook raise, but it is still analyst-driven rather than a new company filing.

Market effects

Reinforces positive read-through for consumer staples names when volume-led growth and profitability beats translate into raised outlooks.

May support UK-listed consumer staples sentiment given the ADR weakness despite the analyst upgrades.

Limited beyond large-cap consumer goods, since the catalyst is company-specific earnings performance and sell-side revisions.

Counterpoint

Target lifts may already be partially priced in after the Q2 beat, so incremental upside could be capped if subsequent quarters fail to sustain volume/mix strength.

Key entities

  • Unilever

    Consumer goods company whose Q2 results triggered analyst target increases and EPS estimate revisions.

  • TD Cowen

    Raised its Unilever price target to $76 from $67, maintaining a Buy rating.

  • BofA

    Raised its Unilever price target to $76 from $72 and increased EPS estimates for 2026-2028 by 1% each.

Related articles

$ULMed

Unilever agrees on worker protection deal following McCormick food merger

Unilever agreed, according to Reuters citing a memo, to protect employment terms for workers in its European and UK food business for two years after its planned merger with US spice maker McCormick. The protection is set to run until at least mid-2029. The deal, agreed in March, values Unilever’s Food unit at about $44.8B and the combined entity at about $65B, expected to close mid-2027 subject to approvals.

$ULMed

Unilever (UL) Q2 2026 Earnings Call Transcript

Unilever PLC (UL) reported Q2 2026 underlying sales growth of 5.8%, driven by underlying volume growth of 5.5%. Power brands rose 6.9% (78% of turnover). First-half turnover was €25.6B (+0.5%), underlying operating margin 20.3%, and underlying EPS €1.61 (+2.4%). Full-year USG upgraded to 4% to 6% and UVG ~3%, with €1.5B free cash flow and €1.5B completed buybacks.

$ULMed

Unilever guarantees worker pay protections after McCormick merger

Reuters reported Unilever has disclosed new worker pay protections tied to its McCormick merger. The combined McCormick-Unilever Foods business will keep agreed terms until at least mid-2029, covering about 4,800 employees in Unilever’s European and British food operations. The European Works Council said the two-year term exceeds typical EU and UK legal requirements.